These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6686775)

  • 1. [Suppression of acid secretion and plasma level of a once-daily dose of omeprazole].
    Müller P; Seitz HK; Simon B; Dammann HG
    Arzneimittelforschung; 1983; 33(12):1685-6. PubMed ID: 6686775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid inhibitory characteristics of omeprazole in man.
    Cederberg C; Ekenved G; Lind T; Olbe L
    Scand J Gastroenterol Suppl; 1985; 108():105-12. PubMed ID: 3858972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.
    Lind T; Cederberg C; Ekenved G; Haglund U; Olbe L
    Gut; 1983 Apr; 24(4):270-6. PubMed ID: 6832622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavior of acid secretion under the long-term daily administration of omeprazol].
    Dammann HG; Müller P; Seitz HK; Simon B
    Schweiz Med Wochenschr; 1983 Jun; 113(24):895-8. PubMed ID: 6348940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in man.
    Wilson JA; Boyd EJ; Wormsley KG
    Dig Dis Sci; 1984 Sep; 29(9):797-801. PubMed ID: 6432499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of omeprazole on gastric acid secretion in man.
    Olbe L; Lind T; Cederberg C; Ekenved G
    Scand J Gastroenterol Suppl; 1986; 118():105-7. PubMed ID: 3460164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
    Howden CW; Forrest JA; Reid JL
    Gut; 1984 Jul; 25(7):707-10. PubMed ID: 6428981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
    Pratha VS; Hogan DL; Lane JR; Williams PJ; Burton MS; Lynn RB; Karlstadt RG
    Dig Dis Sci; 2006 Jan; 51(1):123-31. PubMed ID: 16416224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs.
    De Graef J; Woussen-Colle MC
    Gastroenterology; 1986 Aug; 91(2):333-7. PubMed ID: 2873074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole, a long-lasting inhibitor of gastric secretion.
    Larson GM; Sullivan HW
    J Surg Res; 1984 May; 36(5):503-7. PubMed ID: 6727328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo.
    Larsson H; Mattson H; Sundell G; Carlsson E
    Scand J Gastroenterol Suppl; 1985; 108():23-35. PubMed ID: 3858975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acid secretion inhibition with new mechanisms of action: substituted benzimidazole].
    Olbe L; Lind T; Carlsson E; Cederberg C; Helander H; Wallmark B
    Schweiz Med Wochenschr; 1984 May; 114(20):683-5. PubMed ID: 6740286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study.
    Pisegna JR; Martin P; McKeand W; Ohning G; Walsh JH; Paul J
    Am J Gastroenterol; 1999 Oct; 94(10):2874-80. PubMed ID: 10520836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans.
    Olbe L; Haglund U; Leth R; Lind T; Cederberg C; Ekenved G; Elander B; Fellenius E; Lundborg P; Wallmark B
    Gastroenterology; 1982 Jul; 83(1 Pt 2):193-8. PubMed ID: 6282679
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
    Periclou AP; Goldwater R; Lee SM; Park DW; Kim DY; Cho KD; Boileau F; Jung WT
    Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of omeprazole-induced hypergastrinemia to gastric pH.
    Larson GM; Sullivan HW; Rayford PL
    Surgery; 1986 Aug; 100(2):175-80. PubMed ID: 3738749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Omeprazole and inhibition of gastric acid secretion].
    Rossi G
    Recenti Prog Med; 1984 Apr; 75(4):419-21. PubMed ID: 6729204
    [No Abstract]   [Full Text] [Related]  

  • 19. Human gastric acid secretion following repeated doses of AG-1749.
    Müller P; Dammann HG; Leucht U; Simon B
    Aliment Pharmacol Ther; 1989 Apr; 3(2):193-8. PubMed ID: 2491469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.